本页面由Tiger Trade Technology Pte. Ltd.提供服务

Quoin Pharmaceuticals

4.36
-0.1400-3.11%
盘后:4.360.00000.00%19:59 EDT
成交量:5.09万
成交额:23.12万
市值:2,094.63万
市盈率:-0.51
高:5.31
开:4.83
低:4.30
收:4.50
52周最高:41.80
52周最低:3.25
股本:480.42万
流通股本:462.80万
量比:1.02
换手率:1.10%
股息:- -
股息率:- -
每股收益(TTM):-8.5210
每股收益(LYR):-14.7963
净资产收益率:-575.73%
总资产收益率:-114.60%
市净率:5.33
市盈率(LYR):-0.29

数据加载中...

2023/02/09

SEC问询函

CORRESP [Cover] - Correspondence
2023/02/09

SEC问询函

CORRESP [Cover] - Correspondence
2023/02/09

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2023/02/08

SEC问询函

CORRESP [Cover] - Correspondence
2023/02/03

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2022/08/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/04

SEC问询函

CORRESP [Cover] - Correspondence
2022/08/04

SEC问询函

CORRESP [Cover] - Correspondence
2022/08/04

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/08/03

招股说明书

F-1 - Registration statement for certain foreign private issuers
2022/04/22

SEC问询函

CORRESP [Cover] - Correspondence
2022/04/15

招股说明书

F-1 - Registration statement for certain foreign private issuers
2022/04/14

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/08/10

SEC问询函

CORRESP [Cover] - Correspondence
2021/08/05

SEC问询函

CORRESP [Cover] - Correspondence
2021/08/03

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/07/16

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/29

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]